Drug Information

General Information
Drug ID
DR00337
Drug Name
N-methylpyridinium
Synonyms
1-Methyl-Pyridinium; 1-Methylpyridin-1-ium; 1-Methylpyridinium; N-Methylpyridinium; Pyridinium, 1-methyl-
Drug Type
Small molecular drug
Indication Colon cancer [ICD11: 2B90.Z] Preclinical [1]
Therapeutic Class
Anticancer Agents
Structure
3D MOL 2D MOL
Formula
C6H8N+
Canonical SMILES
C[N+]1=CC=CC=C1
InChI
InChI=1S/C6H8N/c1-7-5-3-2-4-6-7/h2-6H,1H3/q+1
InChIKey
PQBAWAQIRZIWIV-UHFFFAOYSA-N
Pharmaceutical Properties Molecular Weight 94.13 Topological Polar Surface Area 3.9
Heavy Atom Count 7 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 0
XLogP
1.5
PubChem CID
13597
ChEBI ID
ChEBI:15761
DT(s) Transporting This Drug MATE1 Transporter Info Multidrug and toxin extrusion protein 1 Substrate [2]
MATE2 Transporter Info Multidrug and toxin extrusion protein 2 Substrate [2]
OCT-1 Transporter Info Organic cation transporter 1 Substrate [3]
OCT-2 Transporter Info Organic cation transporter 2 Substrate [4]
OCT-3 Transporter Info Organic cation transporter 3 Substrate [5]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MATE1 Transporter Info Km = 16 microM Human embryonic kidney cells (HEK293)-MATE1 [6]
MATE1 Transporter Info Km = 100 microM Human embryonic kidney cells (HEK293)-MATE1 [2]
MATE2 Transporter Info Km = 93.5 microM Human embryonic kidney cells (HEK293)-MATE2K [7]
MATE2 Transporter Info Km = 110 microM Human embryonic kidney cells (HEK293)-MATE2K [2]
OCT-1 Transporter Info Km = 21 microM Madin-Darby canine kidney cells (MDCKII)-OCT1 [3]
OCT-1 Transporter Info Km = 14.6 microM Oocytes-OCT1 [8]
OCT-2 Transporter Info Km = 16 microM Human embryonic kidney cells (HEK293)-OCT2 [9]
OCT-2 Transporter Info Km = 19.5 microM Human embryonic kidney cells (HEK293)-OCT2 [10]
OCT-2 Transporter Info Km = 19.5 microM Human embryonic kidney cells (HEK293)-OCT2 [4]
OCT-2 Transporter Info Km = 19 microM Oocytes-OCT2 [11]
OCT-3 Transporter Info Km = 47 microM Human retinal pigment epithelial (HRPE) cells-OCT3 [5]
References
1 Wikipedia: Methylpyridinium
2 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.
3 Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1. Diabetes. 2008 Jun;57(6):1463-9.
4 Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser. Drug Metab Dispos. 2009 Jun;37(6):1312-8.
5 Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol Renal Physiol. 2000 Sep;279(3):F449-58.
6 A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17923-8.
7 Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol. 2006 Aug;17(8):2127-35.
8 Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol. 1997 Jun;51(6):913-21.
9 Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 1998 Aug;54(2):342-52.
10 Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):337-48.
11 Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 1997 Jul;16(7):871-81.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.